Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CaPE for Bipolar Disorders in Nigeria
NCT05721196Unknown
- Sponsor
- Nottingham Trent University
- Start
- Aug 2023
- Primary completion
- Jun 2024
01
Overview
Randomised, open-label trial (2 arms), sponsored by Nottingham Trent University. Primary endpoint: Pain reduction at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT05721196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05721196.